- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Low levels of anti-MPER antibodies are detectable in viremic HIV infected ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Urheber
-
Carrillo, J.
- Beteiligte Personen und Organisationen
-
Massanella, M.
Marfil, S.
Garcia, E.
Clotet, B.
Blanco, J.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P81
- URN
-
urn:nbn:de:1111-2016080726569
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Carrillo, J.
- Massanella, M.
- Marfil, S.
- Garcia, E.
- Clotet, B.
- Blanco, J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors
Anti-Bodies
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies
Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors
Anti-Bodies
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies
Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors
Anti-Bodies
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing